Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: Impact on restenosis

Circulation

Volumn 115, Issue 5, 2007, Pages 553-561

  Inoue, Teruo ^a   Sata, Masataka ^b   Hikichi, Yutaka ^a   Sohma, Ryoichi ^a   Fukuda, Daiju ^b   Uchida, Toshihiko ^c   Shimizu, Minoru ^c   Komoda, Hiroshi ^a   Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Inflammation; Reendothelialization; Restenosis; Stem cells; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA SMOOTH MUSCLE ACTIN; CD11B ANTIGEN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; INTEGRIN; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CORRELATION ANALYSIS; DRUG ELUTING STENT; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER;

AGED; ANTIGENS, CD34; BONE MARROW CELLS; CELL MOVEMENT; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; STENTS; TIME FACTORS;

EID: 33846886976     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.621714     Document Type: Article

References (36)

1. Liu MW, Roubin GS, King SB 3rd. Restenosis after coronary angioplasty: potential biological determinants and role of intimal hyperplasia. Circulation. 1989;79:1374-1387.
2. Tanaka H, Skhova GK, Swanson SJ, Clinton SK, Ganz P, Cybulsky MI, Libby P. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation. 1993;88(pt 1):1788-1803.
3. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002;22:1769-1776.
4. Rogers C, Parikh S, Scifert P, Edelman ER. Endogenous cell seeding: remnant endothelium after stenting enhances vascular repair. Circulation. 1996;94:2909-2914.
5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-966.
6. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onituka I, Matsui K, Imaizumi T. Transplanted cord blood- derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000;105:1527-1536.
7. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403-409.
8. Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russel SJ, Litzow MR, Edwards WD. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A. 2003;100:4754-4759.
9. Chen CH, Lin W, Shye S, Kibler R, Grenier K, Recktenwald D, Terstappen L. Automated enumeration of CD34 cells in peripheral blood and bone marrow. J Hematol. 1994;3:3-13.
10. Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, Morooka S. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation. 2003;107:1757-1763.
11. Elemer GS, Edgington TS. Two independent sets of monoclonal antibodies define neoepitope linked to soluble ligand binding and leukocyte adhesion functions of activated αMβ2. Circ Res. 1994;75:165-171.
12. Fukuda D, Sata M, Tanaka K, Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation. 2005;111:926-931.
13. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimata T, Oike Y, Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103:2776-2779.
14. Schober A, Hoffmann R, Opree N, Knarren S, Iofina E, Hutschenreuter G, Hanrath P, Weber C. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease. Am J Cardiol. 2005;96:1116-1122.
15. Kawamoto A, Gwaon HC, Iwaguro H, Yamaguchi J, Uchida S, Silver M, Ma H, Keamey M, Isner JM, Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634-637.
16. Welt FG, Ederman ER, Simon DI, Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol. 2000;20:2553-2558.
17. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis. Circulation. 1992;86(suppl III):III-47-III-52.
18. Evangelista V, Manarini S, Sideri R, Rotendo S, Martelli N, Piccoli A, Totani L, Piccardoni P, Vestweber D, de Gaetano G, Cerletti C. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood. 1999;93:876-885.
19. Simon DI, Chen Z, Xu H, Li CQ, Dong J, Mclntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA. Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med. 2000;192:193-204.
20. Rogers C, Edelman ER, Simon DI. A mAb to the β2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci U S A. 1998;95:10134-10139.
21. Simon DI, Chen Z, Seifert P, Ederman ER, Ballantyne CM, Rogers C. Decreased neointimal formation in Mac-1 -/- mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest. 2000;105:293-300.
22. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1996;28:1127-1133.
23. Inoue T, Sakai Y, Hoshi K, Yaguchi I, Fujito T, Morooka S. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation. 1998;97:2511-2518.
24. Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S. Activation process of platelets and neutrophils after coronary stent implantation: comparison with balloon angioplasty. Am J Cardiol. 2000;86:1057-1062.
25. Starckx S, Van den Steen PE, Wuyts A, Van Damme J, Opdenakker G. Neutrophil geratinase B and chemokines in leukocytosis and stem cell mobilization. Leuk Lymphoma. 2002;43:233-241.
26. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Raflii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625-637.
27. Wize J, Sopta I, Smerdel A, Maslinski S. Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of geratinase B (MMP-9) from human neutrophils. Inflamm Res. 1998;47:325-327.
28. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, Ibrahim T, Meisetschlager G, von Wedel J, Bollwein H, Seyfarth M, Dirschinger J, Schmitt C, Schwaiger M, Kastrati A, Schomig A, for the REVIVAL-2 Investigators. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA. 2006;295:1003-1010.
29. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, Kim YJ, Lee DS, Sohn DW, Han KS, Oh BH, Lee MM, Park YB. Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MASIC cell randomized clinical trial. Lancet. 2004;363:751-756.
30. Chen X, Kelemen SE, Autieri MV. Expression of granulocyte-colony stimulating factor is induced in injured rat carotid artery and mediates vascular smooth muscle cell migration. Am J Physiol. 2005;288:C81-C88.
31. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlated with risk factors for coronary artery disease. Circ Res. 2001;89:e1-e7.
32. Simpler D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. Smooth muscle progenitor cells in human blood. Circulation. 2002;106:1199-1204.
33. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissmann NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of anti-platelet therapy. Lancet. 2004;364:1519-1521.
34. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimuseluting stent: should we be cautious? Circulation. 2004;109:701-705.
35. Kutryk MJ, Kuliszewski MA. In vivo endothelial progenitor cell seeding for the accelerated endothelialization of endovascular devices. Am J Cardiol. 2003;92:94L.
36. Aoki J, Serruys PW, van Beusekom H, Ong ATL, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, Kutryk MJB. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First in Man) registry. J Am Coll Cardiol. 2005;45:1574-1579.